Hyperfine (HYPR) Share-based Compensation Growth (3y) (2024 - 2026)
Hyperfine (HYPR) Share-based Compensation Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 3.40% |
| 10 | Hyperfine | 89.93 Mn | 45.16 Mn | 1.98 Mn | -7.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.28% |
| Mar 31, 2026 | -16.86% |
| Dec 31, 2025 | -27.19% |
| Sep 30, 2025 | 31.27% |
| Jun 30, 2025 | -57.45% |
| Mar 31, 2025 | -38.74% |
| Dec 31, 2024 | -0.81% |
| Sep 30, 2024 | -7.11% |
| Jun 30, 2024 | -7.62% |
| Mar 31, 2024 | 56.94% |